Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

Carbognin, Luisa ; Pilotto, Sara ; Milella, Michele ; Vaccaro, Vanja ; Brunelli, Matteo ; Caliò, Anna ; Cuppone, Federica ; Sperduti, Isabella ; Giannarelli, Diana ; Chilosi, Marco ; Bronte, Vincenzo ; Scarpa, Aldo ; Bria, Emilio ; Tortora, Giampaolo Santini, Daniele

PloS one, 2015-06, Vol.10 (6), p.e0130142-e0130142 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível